Chemoprophylaxis against Pneumocystis jirovecii pneumonia in Japanese patients with ANCA-associated vasculitis: an observational study.

Izaya NakayaKen-Ei Sada Masayoshi HarigaiJun SomaKoichi AmanoHiroaki DobashiTatsuya AtsumiYukio YuzawaShouichi FujimotoTakahiko SugiharaYoshinari TakasakiYoshihiro ArimuraHirofumi Makino

Published in: Modern rheumatology (2022)

The markedly low incidence of PCP may be attributed to the continuous chemoprophylaxis against PCP received by >50% of Japanese patients with AAV, though the effectiveness of chemoprophylaxis against PCP was not statistically confirmed.

Keyphrases

randomized controlled trial
systematic review
risk factors
gene therapy
intensive care unit
acute respiratory distress syndrome